What is the share price of Artemis Medicare Services Ltd (ARTEMISMED) today?
The share price of ARTEMISMED as on 17th March 2026 is ₹222.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Artemis Medicare Services Ltd (ARTEMISMED) share?
The past returns of Artemis Medicare Services Ltd (ARTEMISMED) share are- Past 1 week: -3.48%
- Past 1 month: -7.78%
- Past 3 months: -19.99%
- Past 6 months: -7.73%
- Past 1 year: -6.96%
- Past 3 years: 226.82%
- Past 5 years: 905.88%
What are the peers or stocks similar to Artemis Medicare Services Ltd (ARTEMISMED)?
The peers or stocks similar to Artemis Medicare Services Ltd (ARTEMISMED) include:What is the dividend yield % of Artemis Medicare Services Ltd (ARTEMISMED) share?
The current dividend yield of Artemis Medicare Services Ltd (ARTEMISMED) is 0.18.What is the market cap of Artemis Medicare Services Ltd (ARTEMISMED) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Artemis Medicare Services Ltd (ARTEMISMED) is ₹3475.30 Cr as of 17th March 2026.What is the 52 week high and low of Artemis Medicare Services Ltd (ARTEMISMED) share?
The 52-week high of Artemis Medicare Services Ltd (ARTEMISMED) is ₹306.15 and the 52-week low is ₹210.06.What is the PE and PB ratio of Artemis Medicare Services Ltd (ARTEMISMED) stock?
The P/E (price-to-earnings) ratio of Artemis Medicare Services Ltd (ARTEMISMED) is 42.05. The P/B (price-to-book) ratio is 4.12.Which sector does Artemis Medicare Services Ltd (ARTEMISMED) belong to?
Artemis Medicare Services Ltd (ARTEMISMED) belongs to the Industrials sector & Business Support Services sub-sector.How to buy Artemis Medicare Services Ltd (ARTEMISMED) shares?
You can directly buy Artemis Medicare Services Ltd (ARTEMISMED) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Artemis Medicare Services Ltd
ARTEMISMED Share Price
NSE₹222.401.31% (+2.87)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ARTEMISMED Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ARTEMISMED Performance & Key Metrics
ARTEMISMED Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 35.97 | 4.12 | 0.18% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 38.86 | 5.74 | 0.71% |
67%
Analysts have suggested that investors can buy this stock
from 3 analysts
Price Upside
Earnings Growth
Rev. Growth
ARTEMISMED Company Profile
Artemis Medicare Services Ltd is headquartered in Gurgaon, Haryana, India and is a provider of administrative management and general management consulting services. The company was founded in 2009. PTL Enterprises Ltd is its ultimate parent.
KFINTECH
PE Ratio
46.75
46.75
1Y Return
1.37%
1.37%
Buy Reco %
88.89
88.89
INDGN
PE Ratio
25.74
25.74
1Y Return
17.65%
17.65%
Buy Reco %
57.14
57.14
RITES
PE Ratio
23.87
23.87
1Y Return
6.20%
6.20%
Buy Reco %
50.00
50.00
SIS
PE Ratio
332.21
332.21
1Y Return
7.04%
7.04%
Buy Reco %
100.00
100.00
SANGHVIMOV
PE Ratio
12.77
12.77
1Y Return
1.71%
1.71%
Buy Reco %
0.00
0.00
ARTEMISMED Sentiment Analysis
ARTEMISMED Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ARTEMISMED Stock Summary · February 2026
Artemis Medicare demonstrated robust financial performance in Q3, achieving a 17.2% year-on-year revenue growth, driven by increased patient volumes and a strategic focus on high-end medical services. The company is poised for significant expansion, planning to increase bed capacity substantially while enhancing operational efficiencies through digital transformation and AI-assisted systems. Despite challenges in occupancy rates and operational costs, management anticipates improved margins as new facilities come online, particularly in high-demand regions like South Delhi and Raipur. Additionally, a proactive approach to diversifying international patient sources aims to bolster revenue streams, positioning Artemis favorably in the competitive healthcare landscape. Overall, the commitment to quality care and strategic partnerships underscores a promising outlook for sustained growth.
ARTEMISMED Stock Growth Drivers
ARTEMISMED Stock Growth Drivers
7Strong Financial Performance
Artemis Medicare Services Limited has reported significant financial achievements, including a consolidated revenue from operations
Expansion of Bed Capacity and Facilities
The company is actively expanding its infrastructure, with plans to increase bed capacity from 700-800
ARTEMISMED Stock Challenges
ARTEMISMED Stock Challenges
6Delays in Facility Openings
The timeline for the Raipur facility's opening has been pushed back from the end of
Decline in Cardiac Care Segment Performance
The cardiac care segment is facing challenges, with a significant decline in performance metrics. The
ARTEMISMED Forecast
ARTEMISMED Forecasts
Price
Revenue
Earnings
ARTEMISMED Share Price Forecast
ARTEMISMED Share Price Forecast
2026
Current
₹222.40
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹222.40
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
ARTEMISMED Company Revenue Forecast
ARTEMISMED Company Revenue Forecast
2025
Current
₹969.91
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹969.91
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
ARTEMISMED Stock EPS (Earnings Per Share) Forecast
ARTEMISMED Stock EPS (Earnings Per Share) Forecast
2025
Current
₹6.04
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹6.04
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ARTEMISMED
ARTEMISMED
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ARTEMISMED Income Statement
ARTEMISMED Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 227.43 | 220.57 | 227.14 | 227.61 | 248.86 | 241.19 | 252.25 | 261.89 | 282.36 | 279.81 | ||||||||||
Operating & Other expenses | 190.80 | 186.14 | 187.29 | 187.04 | 199.16 | 194.93 | 204.01 | 213.57 | 224.08 | 230.86 | ||||||||||
EBITDA | 36.63 | 34.43 | 39.85 | 40.57 | 49.70 | 46.26 | 48.24 | 48.32 | 58.28 | 48.95 | ||||||||||
| Depreciation/Amortization | 9.95 | 10.16 | 11.04 | 10.80 | 11.17 | 11.45 | 11.74 | 11.16 | 11.71 | 12.44 | ||||||||||
| PBIT | 26.68 | 24.27 | 28.81 | 29.77 | 38.53 | 34.81 | 36.50 | 37.16 | 46.57 | 36.51 | ||||||||||
| Interest & Other Items | 7.88 | 7.96 | 8.57 | 8.13 | 7.98 | 8.00 | 7.83 | 7.38 | 7.19 | 6.75 | ||||||||||
| PBT | 18.80 | 16.31 | 20.24 | 21.64 | 30.55 | 26.81 | 28.67 | 29.78 | 39.38 | 29.76 | ||||||||||
| Taxes & Other Items | 5.20 | 4.75 | 6.05 | 4.98 | 8.29 | 6.14 | 5.63 | 8.51 | 9.41 | 7.42 | ||||||||||
| Net Income | 13.60 | 11.56 | 14.19 | 16.66 | 22.26 | 20.67 | 23.04 | 21.27 | 29.97 | 22.34 | ||||||||||
| EPS | 1.00 | 0.85 | 1.04 | 1.14 | 1.42 | 1.32 | 1.47 | 1.35 | 1.90 | 1.41 |
ARTEMISMED Company Updates
FY 2026FY 2026
Investor Presentation
Feb 2PDF
Nov 11PDF
Aug 6PDF
ARTEMISMED Stock Peers
ARTEMISMED Past Performance & Peer Comparison
ARTEMISMED Past Performance & Peer Comparison
Comparing 3 stocks from
IndustrialsBusiness Support Services
Compare valuation on Screener
IndustrialsBusiness Support Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Artemis Medicare Services Ltd | 42.05 | 4.12 | 0.18% |
| Kfin Technologies Ltd | 46.75 | 11.05 | 0.83% |
| Indegene Ltd | 25.74 | 4.00 | 0.46% |
| RITES Ltd | 23.87 | 3.34 | 3.95% |
ARTEMISMED Stock Price Comparison
Compare ARTEMISMED with any stock or ETFCompare ARTEMISMED with any stock or ETF
ARTEMISMED
ARTEMISMED Holdings
ARTEMISMED Shareholdings
ARTEMISMED Promoter Holdings Trend
ARTEMISMED Promoter Holdings Trend
Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 8.14%
High Pledged Promoter Holding
Lower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
ARTEMISMED Institutional Holdings Trend
ARTEMISMED Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 12.10%
ARTEMISMED Shareholding Pattern
ARTEMISMED Shareholding Pattern
ARTEMISMED Shareholding History
ARTEMISMED Shareholding History
Foreign Institutions
Mutual Funds Invested in ARTEMISMED
Mutual Funds Invested in ARTEMISMED
No mutual funds holding trends are available
Top 5 Mutual Funds holding Artemis Medicare Services Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.8629% | Percentage of the fund’s portfolio invested in the stock 1.77% | Change in the portfolio weight of the stock over the last 3 months -0.30% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 27/36 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.4208% | Percentage of the fund’s portfolio invested in the stock 0.07% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 155/259 (+60) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2795% | Percentage of the fund’s portfolio invested in the stock 1.60% | Change in the portfolio weight of the stock over the last 3 months -0.26% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 16/84 (-12) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ARTEMISMED stock
smallcases containing ARTEMISMED stock
Looks like this stock is not in any smallcase yet.
ARTEMISMED Events
ARTEMISMED Events
ARTEMISMED Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ARTEMISMED Dividend Trend
No dividend trend available
ARTEMISMED Upcoming Dividends
ARTEMISMED Upcoming Dividends
No upcoming dividends are available
ARTEMISMED Past Dividends
ARTEMISMED Past Dividends
Cash Dividend
Ex DateEx DateJul 11, 2025
Final
Final | Div/Share: ₹0.45
Dividend/Share
₹0.45
Ex DateEx Date
Jul 11, 2025
Cash Dividend
Ex DateEx DateJul 5, 2024
Final
Final | Div/Share: ₹0.45
Dividend/Share
₹0.45
Ex DateEx Date
Jul 5, 2024
Cash Dividend
Ex DateEx DateJul 14, 2023
Final
Final | Div/Share: ₹0.45
Dividend/Share
₹0.45
Ex DateEx Date
Jul 14, 2023
ARTEMISMED Stock News & Opinions
ARTEMISMED Stock News & Opinions
Articles & Videos
Earnings
Artemis Medicare Services consolidated net profit rises 8.08% in the December 2025 quarter
Net profit of Artemis Medicare Services rose 8.08% to Rs 22.34 crore in the quarter ended December 2025 as against Rs 20.67 crore during the previous quarter ended December 2024. Sales rose 17.20% to Rs 272.35 crore in the quarter ended December 2025 as against Rs 232.39 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales272.35232.39 17 OPM %16.3616.12 - PBDT45.2838.26 18 PBT32.8426.81 22 NP22.3420.67 8 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Artemis Medicare Services to convene board meeting
Artemis Medicare Services will hold a meeting of the Board of Directors of the Company on 2 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Artemis Medicare Services consolidated net profit rises 34.64% in the September 2025 quarter
Net profit of Artemis Medicare Services rose 34.64% to Rs 29.97 crore in the quarter ended September 2025 as against Rs 22.26 crore during the previous quarter ended September 2024. Sales rose 13.79% to Rs 274.70 crore in the quarter ended September 2025 as against Rs 241.42 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales274.70241.42 14 OPM %18.4317.50 - PBDT51.0941.73 22 PBT39.3830.55 29 NP29.9722.26 35 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Artemis Medicare Services to hold board meeting
Artemis Medicare Services will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Artemis Medicare Services allots 3.06 lakh equity shares under ESOP
Artemis Medicare Services has allotted 3,06,000 equity shares under ESOP on 17 October 2025. With this allotment, the paid up equity share capital has increased to Rs 13,92,38,250 consisting of 13,92,38,250 equity shares of Re 1 each. Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Artemis Medicare Services appoints Head-Investor Relations, M&A and Organization Growth Strategy
Artemis Medicare Services announced the appointment of Rudra Narayan Acharjee as Head-Investor Relations, M&A and Organization Growth Strategy, a Senior Management Personnel of the Company, with effect from 18 September 2025. Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Artemis Medicare Services consolidated net profit rises 27.65% in the June 2025 quarter
Net profit of Artemis Medicare Services rose 27.65% to Rs 21.28 crore in the quarter ended June 2025 as against Rs 16.67 crore during the previous quarter ended June 2024. Sales rose 14.23% to Rs 254.96 crore in the quarter ended June 2025 as against Rs 223.20 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales254.96223.20 14 OPM %16.2316.21 - PBDT40.9432.44 26 PBT29.7821.64 38 NP21.2816.67 28 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Artemis Medicare Services to convene board meeting
Artemis Medicare Services will hold a meeting of the Board of Directors of the Company on 5 August 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Artemis Medicare Services to convene AGM
Artemis Medicare Services announced that the Annual General Meeting(AGM) of the company will be held on 30 July 2025.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Artemis Medicare Services consolidated net profit rises 62.41% in the March 2025 quarter
Net profit of Artemis Medicare Services rose 62.41% to Rs 23.03 crore in the quarter ended March 2025 as against Rs 14.18 crore during the previous quarter ended March 2024. Sales rose 6.51% to Rs 239.90 crore in the quarter ended March 2025 as against Rs 225.24 crore during the previous quarter ended March 2024. For the full year,net profit rose 68.15% to Rs 82.63 crore in the year ended March 2025 as against Rs 49.14 crore during the previous year ended March 2024. Sales rose 6.64% to Rs 936.92 crore in the year ended March 2025 as against Rs 878.57 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales239.90225.24 7 936.92878.57 7 OPM %14.9616.85 -16.2015.11 - PBDT40.4131.28 29 152.83108.77 41 PBT28.6620.24 42 107.6768.45 57 NP23.0314.18 62 82.6349.14 68 Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 11.23%, vs industry avg of 11.25%
Over the last 5 years, market share decreased from 3.24% to 2.62%
Over the last 5 years, net income has grown at a yearly rate of 33.08%, vs industry avg of 12.74%